Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) just unveiled an announcement.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has announced an online conference to discuss its financial results for the fiscal year 2024 and the three-month period ending March 31, 2025. The conference aims to provide investors with a comprehensive understanding of the company’s performance and will be held on June 11, 2025, via a remote network interaction platform.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, is a company incorporated in the People’s Republic of China. It operates within the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products.
See more data about 2TZ stock on TipRanks’ Stock Analysis page.